Cinryze IV (C1 esterase inhibitor [human] IV) / Takeda  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cinryze IV (C1 esterase inhibitor [human] IV) / Takeda
NCT02052141 / 2013-002453-29: Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema

Completed
3
12
Europe, US, RoW
CINRYZE 500, CINRYZE 1000
Shire
Hereditary Angioedema (HAE)
05/17
05/17
NCT02865720: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)

Completed
3
8
Japan
CINRYZE 500 U, CINRYZE 1000 U
Shire
Hereditary Angioedema (HAE)
06/17
06/17

Download Options